1 |
Ogawa R. The most current algorithms for the treatment and prevention of hypertrophic scars and keloids. Plast Reconstr Surg 2010;125:557-68.
DOI
|
2 |
DiPietro LA. Angiogenesis and scar formation in healing wounds. Curr Opin Rheumatol 2013;25:87-91.
DOI
|
3 |
van der Veer WM, Niessen FB, Ferreira JA, et al. Time course of the angiogenic response during normotrophic and hypertrophic scar formation in humans. Wound Repair Regen 2011;19:292-301.
DOI
|
4 |
Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 2007;117:524-9.
DOI
|
5 |
Bock O, Schmid-Ott G, Malewski P, et al. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res 2006;297:433-8.
DOI
|
6 |
Ong CT, Khoo YT, Tan EK, et al. Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretion. J Pathol 2007;211:95-108.
DOI
|
7 |
Danese S. Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flow. Curr Opin Gastroenterol 2007;23:384-9.
DOI
|
8 |
Maruotti N, Cantatore FP, Crivellato E, et al. Angiogenesis in rheumatoid arthritis. Histol Histopathol 2006;21:557-66.
|
9 |
Nomoto H, Shiraga F, Kuno N, et al. Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits. Invest Ophthalmol Vis Sci 2009;50:4807-13.
DOI
|
10 |
Sinapis C, Routsias J, Sinapis D, et al. Pharmacokinetics of intravitreal bevacizumab (Avastin) in rabbits. Invest Ophthalmol Vis Sci 2010;51:2440.
|
11 |
Wang J, Chen H, Shankowsky HA, et al. Improved scar in postburn patients following interferon-alpha2b treatment is associated with decreased angiogenesis mediated by vascular endothelial cell growth factor. J Interferon Cytokine Res 2008;28:423-34.
DOI
|
12 |
Wilgus TA, Ferreira AM, Oberyszyn TM, et al. Regulation of scar formation by vascular endothelial growth factor. Lab Invest 2008;88:579-90.
DOI
|
13 |
Morris DE, Wu L, Zhao LL, et al. Acute and chronic animal models for excessive dermal scarring: quantitative studies. Plast Reconstr Surg 1997;100:674-81.
DOI
|
14 |
Kalluri R, Sukhatme VP. Fibrosis and angiogenesis. Curr Opin Nephrol Hypertens 2000;9:413-8.
DOI
|
15 |
Ko JH, Kim PS, Zhao Y, et al. HMG-CoA reductase inhibitors (statins) reduce hypertrophic scar formation in a rabbit ear wounding model. Plast Reconstr Surg 2012;129:252e-262e.
DOI
|
16 |
Weidner N. Chapter 14. Measuring intratumoral microvessel density. Methods Enzymol 2008;444:305-23.
|
17 |
Ren HT, Hu H, Li Y, et al. Endostatin inhibits hypertrophic scarring in a rabbit ear model. J Zhejiang Univ Sci B 2013;14:224-30.
DOI
|
18 |
Mello GR, Pizzolatti ML, Wasilewski D, et al. The effect of subconjunctival bevacizumab on corneal neovascularization, inflammation and re-epithelization in a rabbit model. Clinics (Sao Paulo) 2011;66:1443-50.
DOI
|